Pulmatrix, Inc. (PULM)
Pulmatrix Market Cap: 9.587M for Jan. 16, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| NovaBay Pharmaceuticals, Inc. | 1.861B |
| Palatin Technologies, Inc. | 16.31M |
| Theriva Biologics, Inc. | 6.586M |
| Oragenics, Inc. | 0.7818M |
| NanoViricides, Inc. | 21.24M |
Market Cap Related Metrics
| PS Ratio | 3195.76 |
| Price to Book Value | 2.026 |
| Price | 2.625 |
| Earnings Yield | -64.88% |